Avid Bioservices, Inc. (CDMO) financial statements (2021 and earlier)

Company profile

Business Address 2642 MICHELLE DRIVE, SUITE 200
TUSTIN, CA 92780
State of Incorp. DE
Fiscal Year End April 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2021
TTM
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71363242476168
Cash and cash equivalents71363242476168
Receivables27974834
Inventory, net of allowances, customer advances and progress billings121171633167
Inventory121171633167
Prepaid expense  111  
Other undisclosed current assets6445 11
Total current assets:116605168898281
Noncurrent Assets
Operating lease, right-of-use asset1920
Property, plant and equipment32272626242415
Restricted cash and investments   111 
Other noncurrent assets0000422
Other undisclosed noncurrent assets001    
Total noncurrent assets:52482728292717
TOTAL ASSETS:168108789611810997
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13984162219
Accounts payable76426810
Accrued liabilities    584
Employee-related liabilities7343665
Deferred revenue4829
Debt 4     
Disposal group, including discontinued operation   5   
Deferred revenue and credits 29107
Customer advances and deposits 172411
Contract with customer, liability15
Other liabilities0111110
Other undisclosed current liabilities11 28   
Total current liabilities:63442338635837
Noncurrent Liabilities
Long-term debt and lease obligation20210    
Capital lease obligations0    
Operating lease, liability2021
Liabilities, other than long-term debt  22211
Deferred revenue and credits 211
Deferred rent credit  22
Other undisclosed noncurrent liabilities(20)(21)     
Total noncurrent liabilities:202122211
Total liabilities:83662540655938
Stockholders' equity
Stockholders' equity attributable to parent85425356545059
Preferred stock0000000
Common stock0000000
Additional paid in capital647613614615591559512
Accumulated deficit(562)(571)(561)(559)(537)(509)(454)
Total stockholders' equity:85425356545059
TOTAL LIABILITIES AND EQUITY:168108789611810997

Income statement (P&L) ($ in millions)

1/31/2021
TTM
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
Revenues81605454584527
Revenue, net 584527
Cost of revenue(61)(56)(46)(57)(38)(23)(16)
Cost of goods and services sold(47)(56)  (38)(23)(16)
Other undisclosed gross profit     (0)(0)
Gross profit:2047(3)192111
Operating expenses(16)(15)(13)(16)(48)(78)(62)
Other operating income (expense), net    (0)(0)0
Other expenses    (0)(0) 
Other undisclosed operating income (loss)   (1)00(0)
Operating income (loss):4(11)(6)(21)(28)(56)(50)
Interest and debt expense      (0)
Income (loss) from continuing operations before equity method investments, income taxes:4(11)(6)(21)(28)(56)(51)
Other undisclosed income from continuing operations before income taxes0000   
Income (loss) from continuing operations before income taxes:4(10)(5)(21)(28)(56)(51)
Income tax benefit 20   22
Other undisclosed loss from continuing operations (2)     
Income (loss) from continuing operations:4(10)(5)(21)(28)(56)(29)
Income (loss) from discontinued operations  1(1)   
Net income (loss):4(10)(4)(22)(28)(56)(29)
Other undisclosed net income (loss) attributable to parent0   01(21)
Net income (loss) attributable to parent:4(10)(4)(22)(28)(56)(50)
Preferred stock dividends and other adjustments(5)(5)(5)(5)(5)(4)4
Other undisclosed net loss available to common stockholders, basic      (7)
Net loss available to common stockholders, diluted:(1)(15)(9)(26)(33)(60)(54)

Comprehensive Income ($ in millions)

1/31/2021
TTM
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
Net income (loss):4(10)(4)(22)(28)(56)(29)
Comprehensive income (loss):4(10)(4)(22)(28)(56)(29)
Comprehensive loss, net of tax, attributable to noncontrolling interest(4)      
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    01(21)
Comprehensive loss, net of tax, attributable to parent:(0)(10)(4)(22)(28)(56)(50)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: